COVID-19

Arbutus Moderna RNAi LNP IP Patent COVID-19

Is Moderna’s LNP Technology a Patent Infringement against Arbutus

According to Mark Murry (CEO of Arbutus), “We have seen no evidence of a Moderna delivery system that is free of our intellectual property. Not in their publications, their presentations, or in the examples in their patent filings.” Read more about this in a Forbes article: Moderna Can’t Escape My Intellectual Property, Says Arbutus CEO …

Is Moderna’s LNP Technology a Patent Infringement against Arbutus Read More »

virus stock Moderna

Moderna CEO Dumping Thousands of Shares

Moderna’s Stephane Bancel Dumping Stocks Regularly Moderna’s CEO Stephane Bancel has been regularly  dropping thousands of shares of his company’s stock prior to the much anticipated trial data for Moderna’s COVID-19 vaccine trial candidate, mRNA-1273. How confident can he be in the long-term situation for his company? Does he think his company is overvalued? He’s …

Moderna CEO Dumping Thousands of Shares Read More »